Arcturus Therapeutics
ARCT
ARCT
53 hedge funds and large institutions have $65.7M invested in Arcturus Therapeutics in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 18 increasing their positions, 15 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.19% more ownership
Funds ownership: 30.08% → 31.28% (+1.2%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
13% less call options, than puts
Call options by funds: $1.58M | Put options by funds: $1.81M
Holders
53
Holding in Top 10
1
Calls
$1.58M
Puts
$1.81M
Top Buyers
| 1 | +$3.56M | |
| 2 | +$2.46M | |
| 3 | +$1.36M | |
| 4 |
Goldman Sachs
New York
|
+$708K |
| 5 |
Morgan Stanley
New York
|
+$591K |
Top Sellers
| 1 | -$2.51M | |
| 2 | -$1.65M | |
| 3 | -$715K | |
| 4 |
Squarepoint
New York
|
-$594K |
| 5 |
JPMorgan Chase & Co
New York
|
-$586K |